Literature DB >> 27441306

Investigating for pulmonary embolism in pregnancy: Five year retrospective review of referrals to the acute medical unit of a large teaching hospital.

Elizabeth Janette Hamilton1, Alistair Quentin Green2, Jennifer Ann Cook3, Henry Nash4.   

Abstract

This was a retrospective review of five years' data relating to patients referred to the Acute Medical Unit (AMU) of a large teaching hospital with suspected Pulmonary Embolism (PE) during pregnancy or 6 weeks postpartum. During this period, 210 patients in this group underwent half-dose perfusion scanning as investigation for possible PE and were managed via our ambulatory pathway. Pulmonary embolism was diagnosed in 5.2% of patients compared to 18% of non-pregnant patients identified in a previous audit. Half-dose Q scanning enabled exclusion of PE in almost 90% of patients without the need for further imaging. A new local pathway for the investigation and management of PE during pregnancy has now been developed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27441306

Source DB:  PubMed          Journal:  Acute Med        ISSN: 1747-4884


  3 in total

1.  Intrapartum Respiratory Distress.

Authors:  S W Steven Shaw
Journal:  J Med Ultrasound       Date:  2017-06-03

2.  Computed tomography pulmonary angiography versus ventilation-perfusion lung scanning for diagnosing pulmonary embolism during pregnancy: a systematic review and meta-analysis.

Authors:  Cécile Tromeur; Liselotte M van der Pol; Pierre-Yves Le Roux; Yvonne Ende-Verhaar; Pierre-Yves Salaun; Christophe Leroyer; Francis Couturaud; Lucia J M Kroft; Menno V Huisman; Frederikus A Klok
Journal:  Haematologica       Date:  2018-08-16       Impact factor: 9.941

Review 3.  Pulmonary Embolism and Pregnancy-Challenges in Diagnostic and Therapeutic Decisions in High-Risk Patients.

Authors:  Lukas Hobohm; Ioannis T Farmakis; Thomas Münzel; Stavros Konstantinides; Karsten Keller
Journal:  Front Cardiovasc Med       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.